BMRA
Biomerica Inc
NASDAQ: BMRA · HEALTHCARE · MEDICAL DEVICES
$2.18
+0.93% today
Updated 2026-04-30
Market cap
$6.61M
P/E ratio
—
P/S ratio
1.53x
EPS (TTM)
$-1.61
Dividend yield
—
52W range
$2 – $5
Volume
0.0M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F6.5
Quality
B2.0
Profitability
F6.7
Valuation
B3/9
Piotroski F-Score
Weak
-12.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$13.00
+496.33%
12-Month target
—
—
Intrinsic (DCF)
$6.01
Margin of safety
+62.06%
Price chart
X-Ray snapshot
Strengths
+ 62.06% below intrinsic value
+ Debt/equity 0.06x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -12.51 — distress zone
- Thin margins at -96.50%
- Negative free cash flow $-1.29M
- Revenue declining -11.80% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $18.87M | $5.34M | $5.42M | $5.31M | $4.33M |
| Net income | $-4.53M | $-7.14M | $-5.98M | $-4.97M | $-1.31M |
| EPS | — | — | — | — | $-1.61 |
| Free cash flow | $-650868.00 | $-5.55M | $-5.48M | $-3.88M | $-1.29M |
| Profit margin | -24.01% | -133.73% | -110.40% | -93.64% | -96.50% |
Peer comparison
Smart narrative
Biomerica Inc trades at $2.18. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -12.51, it sits in the distress. TTM revenue stands at $4.33M. with profit margins at -96.50%. Our DCF model estimates intrinsic value at $6.01.
Frequently asked questions
What is Biomerica Inc's stock price?
Biomerica Inc (BMRA) trades at $2.18.
Is Biomerica Inc overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell). DCF value $6.01.
What is the price target of Biomerica Inc (BMRA)?
The analyst target price is $13.00, representing +496.3% upside from the current price of $2.18.
What is the intrinsic value of Biomerica Inc (BMRA)?
Based on our DCF model, intrinsic value is $6.01, a +62.1% margin of safety versus $2.18.
What is Biomerica Inc's revenue?
TTM revenue is $4.33M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-12.51 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.53x
ROE-94.30%
Beta0.20
50D MA$2.12
200D MA$2.63
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—